#1
Posted: Fri Mar 13, 2026 12:36 am
Johnson & Johnson's nipocalimab has been granted U.S. Food and Drug Administration Fast Track designation as a potential treatment for adults with systemic lupus erythematosus (SLE).
Source: https://medicalxpress.com/news/2026-03- ... lupus.html
Source: https://medicalxpress.com/news/2026-03- ... lupus.html